Virtu Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.39M Buy
+12,582
New +$1.22M 0.05% 225
2025
Q4
– Sell
-11,238
Closed -$824K – 1875
2025
Q3
$824K Sell
11,238
-10,864
-49% -$722K 0.05% 384
2025
Q2
$1.15M Buy
22,102
+8,307
+60% +$473K 0.06% 307
2025
Q1
$880K Buy
13,795
+7,234
+110% +$420K 0.05% 327
2024
Q4
$314K Sell
6,561
-1,026
-14% -$52.6K 0.02% 679
2024
Q3
$434K Buy
+7,587
New +$435K 0.02% 506
2024
Q1
– Sell
-16,421
Closed -$607K – 1682
2023
Q4
$607K Buy
+16,421
New +$618K 0.05% 340
2022
Q3
– Sell
-19,102
Closed -$840K – 1911
2022
Q2
$840K Buy
+19,102
New +$826K 0.07% 257
2021
Q2
– Sell
-7,384
Closed -$308K – 1731
2021
Q1
$308K Sell
7,384
-177
-2% -$8.08K 0.02% 804
2020
Q4
$323K Buy
+7,561
New +$272K 0.03% 611
2020
Q3
– Sell
-12,979
Closed -$348K – 1252
2020
Q2
$348K Buy
+12,979
New +$293K 0.04% 499
2018
Q3
– Sell
-13,319
Closed -$225K – 1804
2018
Q2
$225K Buy
+13,319
New +$252K 0.01% 1412
2018
Q1
– Sell
-19,045
Closed -$386K – 2206
2017
Q4
$386K Sell
19,045
-11,490
-38% -$211K 0.02% 1052
2017
Q3
$530K Buy
+30,535
New +$414K 0.03% 886

Other funds holding HALO

Virtu Financial's HALO Position: Q3 2026 in Review

Virtu Financial opened a new position in Halozyme (HALO) in Q3 2026: 12,582 shares worth $1.39M. The stake represents 0.05% of the portfolio and ranks #225 among its holdings. This is a return to the name: Virtu Financial previously reported a position in HALO as recently as Q3 2025.

Virtu Financial first reported a position in HALO in Q3 2017 and has held it in 14 quarters since. 771 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Virtu Financial held 12,582 shares of Halozyme worth $1.39M as of Q3 2026.
  • Halozyme was a new Virtu Financial position in Q3 2026.
  • Halozyme made up 0.05% of Virtu Financial's portfolio in Q3 2026, its #225 holding.
  • Virtu Financial first reported a position in Halozyme in Q3 2017 and has held it in 14 quarters since.
  • 771 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.